Amneal Pharmaceuticals (AMRX) Net Income (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Net Income of $78.0 million for Q1 2026, up 216.84% year-over-year from $24.6 million in Q1 2025, and up 57.34% quarter-over-quarter from $49.6 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Net Income (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Net Income history runs 10 years deep, the most recent figure standing at $78.0 million for Q1 2026.
- In Q1 2026, Net Income rose 216.84% year-over-year to $78.0 million; the TTM figure through Mar 2026 stood at $181.3 million (up 459.27% YoY), while the FY2025 annual figure was $127.9 million, up 273.17% from the prior year.
- Net Income for Q1 2026 stood at $78.0 million, up from $49.6 million in the prior quarter.
- The five-year high for Net Income was $78.0 million in Q1 2026, with the low at -$240.1 million in Q2 2022.
- The 5-year median for Net Income is $11.8 million (2024), against an average of -$10.1 million.
- Peak annual rise in Net Income reached 1147.41% in 2023, while the deepest fall reached 1504.68% in 2023.
- Amneal Pharmaceuticals' Net Income stood at -$5.8 million in 2022, then plunged by 1504.68% to -$93.3 million in 2023, then soared by 77.78% to -$20.7 million in 2024, then surged by 339.0% to $49.6 million in 2025, then surged by 57.34% to $78.0 million in 2026.
- Business Quant data shows AMRX's Net Income at $78.0 million in Q1 2026, $49.6 million in Q4 2025, and $18.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.43 Bn | 43.46 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.68 Bn | 40.02 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 32.49 Bn | 30.82 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 22.09 Bn | 19.42 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 19.03 Bn | 18.14 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.03 Bn | 11.50 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.77 Bn | 5.65 Bn | 334.51 Mn | 69.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.61 Mn |
| Mar 31, 2026 | 78.00 Mn |
| Dec 31, 2025 | 49.57 Mn |
| Sep 30, 2025 | 18.13 Mn |
| Jun 30, 2025 | 35.61 Mn |
| Mar 31, 2025 | 24.62 Mn |
| Dec 31, 2024 | -20.74 Mn |
| Sep 30, 2024 | 11.76 Mn |
| Jun 30, 2024 | 16.79 Mn |
| Mar 31, 2024 | -81.68 Mn |
| Dec 31, 2023 | -93.34 Mn |
| Sep 30, 2023 | 25.03 Mn |
| Jun 30, 2023 | 29.66 Mn |
| Mar 31, 2023 | -10.13 Mn |
| Dec 31, 2022 | -5.82 Mn |
| Sep 30, 2022 | -2.39 Mn |
| Jun 30, 2022 | -240.08 Mn |
| Mar 31, 2022 | -6.46 Mn |
| Dec 31, 2021 | -20.46 Mn |
| Sep 30, 2021 | -6.04 Mn |